Navigation Links
EaglePicher Medical Power Announces New Li/CFx Battery Technology
Date:5/11/2009

Enhanced design now features End-of-Life capability and longer life

PLANO, Texas, May 11 /PRNewswire/ -- EaglePicher Medical Power, LLC, a leading supplier of batteries for implantable medical devices, today announced the introduction of its enhanced Lithium Carbon Monofluoride (Li/CFx) battery technology with end-of-life capability superior to currently available products in the market. The technology includes a proprietary new Elective Replacement Indicator (ERI) / End of Life (EOL) Indicator to accurately predict battery depletion six months in advance, potentially requiring fewer replacement surgeries over time.

"This enhanced chemistry delivers several benefits - to device manufacturers, physicians and patients. In addition to the new end-of-life feature, this proprietary chemistry provides superior energy density for longer battery life," said Joe Marotta, vice president and general manager of EaglePicher Medical Power. "It gives us great pride to announce a technology that will help improve the lives of patients who rely on implantable medical devices."

The enhanced Li/CFx battery chemistry provides higher energy density for use in a variety of implantable applications including telemetry-capable pacemakers and ICDs, neurostimulation devices, drug pumps, body fluid pumps and monitors.

Benefits include:

  • Proprietary ERI/EOL indicator for safe and predictable replacement prior to end of battery life
  • Superior energy density enabling longer life or potentially smaller devices
  • Excellent rate capability for rapid capacitor charging throughout most of the battery life
  • Telemetry capability
  • Elimination of the initial voltage delay commonly seen in Li/CFx batteries
  • Low self-discharge

The new technology will be available in a number of configurations ranging from under 350 mAh to 10 Ah.

For more information about EaglePicher Medical Power and the new Li/CFx technology, please visit the company's exhibit (booth #1471) at this week's Heart Rhythm 2009 conference and exhibition in Boston.

About EaglePicher Medical Power

Headquartered in Plano, Texas, EaglePicher Medical Power, LLC is an EaglePicher company and a world-leading supplier of batteries to manufacturers of implantable medical devices. Products include batteries for cardio defibrillators, heart monitors, heart re-synchronizers and neuromodulation systems.

EaglePicher Medical Power, one of the few producers of implantable-grade batteries in the world to be certified ISO 13485, leads the industry in producing rechargeable lithium-ion batteries for implantable applications. Building upon the world-class technology heritage of parent EaglePicher, the company offers one of the broadest ranges of electrochemistries for implantable applications including lithium-ion, lithium manganese dioxide, lithium thionyl chloride and lithium carbon monofluoride.


'/>"/>
SOURCE EaglePicher Medical Power, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. EaglePicher Medical Power Names Joseph Marotta Vice President of Sales and Marketing
2. EaglePicher Technologies Introduces First Implantable Medical Cell Designed Specifically for Monitoring Applications
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Celebrates Successful First Year
5. New Board Members Join American College of Medical Genetics Foundation (ACMGF): Distinguished Executive, Medical and Philanthropic Leaders Bring Additional Perspectives to the ACMGF Board
6. Optasia Medical, Ltd. Achieves ISO 9001 and ISO 13485 Certification
7. Palomar Medical to Market Quantels SINON Tattoo Removal Laser in the United States and Canada
8. The EntreTech Forum Presents ... PHOTONICS/OPTICS - Understanding the Latest Applications of Light-based Technologies in Medical, Consumer, Industrial, and Defense Sectors
9. AMPM to Provide Medical Billing Services for Seton Community Health Centers in Austin
10. 7 of 10 women are uninsured or underinsured, or have medical bill, debt, access problems
11. 100% Invisible Lyric(R) Hearing Aid Wins Medical Design Excellence Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... Paul Yost, will begin serving as new board chair for Orange County health ... will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which runs ...
(Date:3/28/2017)... Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... people suffering from acne, access to quality care can be limited while the desire ... company that offers customized prescription acne care for every customer online, today released its ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Executives, Staff & Clients ... to for the Toys for Tots Literacy Campaign at their Semi-Annual Graduation and Fundraiser ... $70 billion, the U.S. ranks at number 14 internationally in literacy. Statistically, a direct ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... offered by the American Association of Integrative Medicine and available for application on ... at the AutismOne 2017 Conference in Colorado Springs. , Ed Arranga, president of ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... Tri-State Camp Conference in Atlantic City March 13-16, was a busy spot this ... of professional staff discussed strategies for preventing outbreaks among camp communities during the ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... This morning,s research on ... The Medicines Co. (NASDAQ: MDCO), Ironwood Pharmaceuticals Inc. ... Supernus Pharmaceuticals Inc. (NASDAQ: SUPN ). ... which is governed by the same governing framework ... industry are wholesalers, retailers, pharmacies, and benefit managers. Learn ...
(Date:3/28/2017)... , March 28, 2017  AcelRx Pharmaceuticals, ... on the development and commercialization of innovative therapies ... that the European Medicines Agency (EMA) has notified ... 30 mcg) Marketing Authorisation Application (MAA) has passed ... MAA is underway. The MAA for ARX-04 (known ...
(Date:3/28/2017)... FRANCISCO , March 28, 2017 ...  is expected to reach a value of USD 4.5 ... Grand View Research, Inc. Proper closure of injured tissues ... structure and function. Postoperative leakages occur in 3% to ... complication. They are responsible for one third of postoperative ...
Breaking Medicine Technology: